Back to results
US 9,789,117 B2Granted
Use of sigma ligands in diabetes type-2 associated pain
AssigneeLaboratorios Del Dr. Esteve, S.A.
InventorsJose Miguel Vela Hernandez, Maria Isabel Martin Fontelles
Life of this patent
Estimating the term…
Abstract
The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat type-2 diabetes-associated pain and related symptoms.
Claims6
A method for treating type-2 diabetes-associated pain selected from the group consisting of allodynia, hyperalgesia and hyperpathia, the method comprising:
- administering a therapeutically effective amount of 4-{2-[5-Methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine, a pharmaceutically acceptable salt thereof, or solvate thereof to a patient in need thereof.
Dependencies are inferred from the claim text.